The expression of several noteworthy genes was observed in the protected participants 7 days after challenge: VTI1B encodes a soluble NSF attachment protein receptor (SNARE) protein and was observed to be strongly upregulated in nTD participants 7 days after challenge. The gene discussed is VTI1B; the disease is neural tube defect.